Fennec Pharmaceuticals In... (FENC)
NASDAQ: FENC
· Real-Time Price · USD
6.39
-0.09 (-1.39%)
At close: May 14, 2025, 3:59 PM
Fennec Pharmaceuticals Revenue Breakdown
| Period Ending | Dec 31, 2020 |
|---|---|
| Royalty Revenue | 170K |
| Royalty Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 8.14M | 10.72M | 11.54M | 11.08M | 10.84M | 7.19M | 7.83M | 6.85M | 7.47M | 7.05M | 3.88M | 2.11M | 3.68M | 2.93M | 3.12M | 2.51M | 2.29M | 4.49M | 3.72M | 2.44M | 2.48M | 1.07M | 2.84M | 1.01M | 1.38M | 1.05M | 1.87M | 1.1M | 1.63M | 1.69M | 1.15M | 546K | 972K | 452K | 568K | 407K | 480K | 250K | 495K | 409K |
| Selling, General, and Administrative Revenue Growth | -24.08% | -7.06% | +4.11% | +2.26% | +50.73% | -8.25% | +14.41% | -8.29% | +5.87% | +81.87% | +83.88% | -42.75% | +25.69% | -6.06% | +24.45% | +9.33% | -48.94% | +20.60% | +52.50% | -1.57% | +132.30% | -62.45% | +181.86% | -26.99% | +31.62% | -43.76% | +69.42% | -32.35% | -3.84% | +47.82% | +109.89% | -43.83% | +115.04% | -20.42% | +39.56% | -15.21% | +92.00% | -49.49% | +21.03% | n/a |
| Research and Development Revenue | 50K | 97K | 157K | 3K | 32K | 12K | 8K | 4K | 117K | 846K | 1.13M | 1.44M | 523K | 1.24M | 800K | 2.42M | 1.22M | 1.37M | 1.12M | 1.39M | 1.17M | 795K | 1.97M | 1.67M | 1.72M | 1.8M | 798K | 689K | 886K | 492K | 333K | 225K | 174K | 112K | 139K | 47K | 71K | 88K | 54K | 43K |
| Research and Development Revenue Growth | -48.45% | -38.22% | +5133.33% | -90.62% | +166.67% | +50.00% | +100.00% | -96.58% | -86.17% | -25.20% | -21.29% | +174.76% | -57.89% | +55.25% | -66.89% | +97.55% | -10.60% | +22.03% | -19.53% | +18.86% | +47.42% | -59.62% | +17.83% | -3.02% | -4.17% | +125.31% | +15.82% | -22.23% | +80.08% | +47.75% | +48.00% | +29.31% | +55.36% | -19.42% | +195.74% | -33.80% | -19.32% | +62.96% | +25.58% | n/a |
| Sales and Marketing Revenue | 3.94M | 4.6M | 4.67M | 5.21M | 3.87M | 3.38M | 2.34M | 2.53M | 2.79M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue Growth | -14.28% | -1.52% | -10.31% | +34.67% | +14.30% | +44.62% | -7.55% | -9.12% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |